As an initial step, conducting in vitro M.tb killing assays (M.tb‐infected macrophages with either CD4+ T cells, CD8+ T cells, or both) would provide a foundational understanding of how mito‐transfer might enhance human T cell‐mediated immunity against TB in a controlled environment. This evidence concerns the gene CD4 and tuberculosis.